Medindia
Medindia LOGIN REGISTER
Advertisement

Pharma Manufacturing Quality: Optimizing Processes for FDA Compliance

Saturday, April 19, 2008 General News
Advertisement
CHAPEL HILL, N.C., April 18 With safety issues makingheadlines, pharmaceutical and medical device manufacturers face a ruggedregulatory landscape. Organizations are relying on their quality function tonavigate regulatory difficulties that could affect production. Proper staffingof quality roles is just one way organizations optimize their quality functionand a study by pharmaceutical benchmarking leader Best Practices, LLC foundbest-in-class companies have a ratio of quality personnel to totalmanufacturing employees between 1:4 and 1:7.
Advertisement

As captured in the benchmarking report, The Quality Function: Structure,Staffing and Execution, Best Practices, LLC, reveals strategic best practicesin quality harnessed from survey responses and in-depth interviews with seventop pharmaceutical and medical device company leaders. A complementaryexcerpt is available at http://www3.best-in-class.com/rr930.htm .
Advertisement

Executives from Abbott, Lilly, J&J, GlaxoSmithKline, Wyeth and othersshared wisdom and key insights for honing elite quality functions within theirorganizations. A sampling of their tactics and best practices includes:

To find out more about Best Practices Research and Consulting, pleasevisit our website at www.best-in-class.com or contact Grant Houston at919-767-9182 or [email protected].

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts workbased on the principle that organizations can chart a course to superioreconomic performance by studying the best business practices, operatingtactics and winning strategies of world-class companies. For more information,call (919) 403-0251 or visit http://www3.best-in-class.com/.* Heighten intra- and inter-company transparency: Disseminate information about weak areas within the company and competitor companies among quality staff, as reflected in regulatory consent decrees and warning letters obtained from FDC publications and Gold/Green/Pink Sheets. * Establish action-triggering metrics: Develop reporting mechanisms that bring performance measurements and deviation reports before the eyes of senior management. * Focus quality personnel on activities/results not measures: Employ integrated improvement charts to effectively communicate important measures to focus actions by responsible parties. E.g., 3-in-1 charts

SOURCE Best Practices, LLC
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close